Novartis Tops Pfizer and GSK In South Korea's 2009 Insurance-covered Drug Sales
This article was originally published in PharmAsia News
SEOUL - Novartis Korea edged Pfizer Korea and GlaxoSmithKline Korea last year to be the country's multinational pharma leader in sales for drugs covered by South Korea's national health insurance system
You may also be interested in...
HONG KONG - Rapid economic growth and the potential for the pharmaceutical industry in Asia go beyond China. A number of companies are boosting their regional presence, aware that focusing exclusively on Chinese growth may ignore the vast potential in other countries in Asia
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).